A detailed history of Lsv Asset Management transactions in Emergent Bio Solutions Inc. stock. As of the latest transaction made, Lsv Asset Management holds 21,600 shares of EBS stock, worth $166,536. This represents 0.0% of its overall portfolio holdings.

Number of Shares
21,600
Holding current value
$166,536
% of portfolio
0.0%

Shares

15 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q4 2024

Feb 13, 2025

BUY
$7.72 - $11.97 $166,752 - $258,552
21,600 New
21,600 $206,000
Q2 2023

Aug 02, 2023

SELL
$7.35 - $13.21 $224,733 - $403,908
-30,576 Reduced 42.9%
40,700 $299,000
Q1 2023

May 02, 2023

SELL
$7.79 - $16.29 $267,976 - $560,376
-34,400 Reduced 32.55%
71,276 $738,000
Q1 2022

May 12, 2022

BUY
$36.48 - $52.22 $518,015 - $741,524
14,200 Added 15.52%
105,676 $4.34 Million
Q4 2021

Jan 28, 2022

BUY
$33.11 - $55.01 $2.03 Million - $3.37 Million
61,176 Added 201.9%
91,476 $3.98 Million
Q1 2021

Apr 30, 2021

SELL
$86.23 - $125.19 $232,821 - $338,013
-2,700 Reduced 8.18%
30,300 $2.82 Million
Q4 2020

Feb 08, 2021

BUY
$79.17 - $111.47 $562,107 - $791,437
7,100 Added 27.41%
33,000 $2.96 Million
Q2 2020

Aug 05, 2020

SELL
$54.33 - $89.52 $249,918 - $411,792
-4,600 Reduced 15.08%
25,900 $2.05 Million
Q1 2020

May 07, 2020

BUY
$49.34 - $68.76 $1.5 Million - $2.1 Million
30,500 New
30,500 $1.76 Million
Q4 2018

Feb 05, 2019

SELL
$55.63 - $73.24 $984,651 - $1.3 Million
-17,700 Closed
0 $0
Q3 2018

Nov 06, 2018

SELL
$52.05 - $66.51 $2.8 Million - $3.57 Million
-53,700 Reduced 75.21%
17,700 $1.17 Million
Q2 2018

Aug 08, 2018

SELL
$48.33 - $55.64 $6.97 Million - $8.02 Million
-144,200 Reduced 66.88%
71,400 $3.6 Million
Q1 2018

May 04, 2018

SELL
$44.44 - $54.39 $23.6 Million - $28.9 Million
-530,918 Reduced 71.12%
215,600 $11.4 Million
Q4 2017

Feb 01, 2018

BUY
$37.77 - $47.75 $3.44 Million - $4.34 Million
90,971 Added 13.88%
746,518 $0
Q3 2017

Nov 13, 2017

BUY
$34.14 - $40.45 $22.4 Million - $26.5 Million
655,547
655,547 $26.5 Million

Others Institutions Holding EBS

About Emergent BioSolutions Inc.


  • Ticker EBS
  • Exchange NYSE
  • Sector Healthcare
  • Industry Drug Manufacturers—Specialty & Generic
  • Shares Outstandng 49,861,500
  • Market Cap $384M
  • Description
  • Emergent BioSolutions Inc., a life sciences company, focuses on the provision of preparedness and response solutions that address accidental, deliberate, and naturally occurring public health threats (PHTs) in the United States. The company's products address PHTs, which include chemical, biological, radiological, nuclear, and explosives; emergi...
More about EBS
Track This Portfolio

Track Lsv Asset Management Portfolio

Follow Lsv Asset Management and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Lsv Asset Management, based on Form 13F filings with the SEC.

News

Stay updated on Lsv Asset Management with notifications on news.